# Blair M. Brengle, M.D. – FDA Inspection, Aug 29, 2024

Source: https://www.keypedia.com/records/fda_inspections/blair-m-brengle-md/f6682fb3-81e0-4c30-8951-16984b32103f
Source feed: FDA_Inspections

> FDA inspection 1247858 of Blair M. Brengle, M.D., August 29, 2024. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1247858
- Company Name: Blair M. Brengle, M.D.
- Inspection Date: 2024-08-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1145665 - 2021-07-08](https://www.keypedia.com/records/fda_inspections/blair-m-brengle-md/f3c8ac6b-552d-4b90-a25a-f008de0cfef1)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/corrine-m-carter/69e1be8c-1cd9-48d9-a08e-bf49060b94d6)
- [Issuing Officer](https://www.keypedia.com/people/victoria-r-flournoy/f8bdf401-7e11-4706-9d36-d8eab4fe46ff)

Company: https://www.keypedia.com/companies/blair-m-brengle-md/20e818ec-0aec-4e25-87ac-4e6e195a9bd4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
